… This is consistent with what has been described in the literature regarding the prevalence
of bronchiolar disorders, particularly CB, among patients with various CTDs. Thus, in patients …

… bronchiolitis because of the mass production of an RSV vaccine, which is under further clinical
studies (25). Another ideal strategy in the treatment of acute bronchiolitis in … bronchioles. …

… vary depending on the cause and stage of bronchiolitis obliterans. In a mouse model of
bronchiolitis obliterans, the bronchiolar epithelium was damaged after hematopoietic stem cell …

… of the terminal and respiratory bronchioles is considered to … to stabilize constrictive bronchiolitis
after hematopoietic stem … in patients with bronchiolitis obliterans syndrome after HSCT …

… bronchiole lumens that are characteristic of bronchiolitis),29 but also because of immunologic
factors (the function of all components of the innate immunity system, an early first line of …

… disorder of bronchi and bronchioles that results in intermittent and reversible bronchospasm
[46]. Clinical features of the disorder … -existent emphysema and bronchiolitis results in airflow …

… Bronchiolitis obliterans (BO) is in general a rare and life-threatening form of non-reversible
obstructive lung disease in which the bronchioles … We considered that ventilation disorders …

… The RSV initiates replication in the mucosa of the nasal epithelium and the inflammatory
lesion will spread to the terminal bronchiole, determining AVB. The inflammatory lesion is …

… Bronchiolitis results from damage to the bronchiolar epithelium, resulting in some degree of
… of disorders. Thus, two classification schemes appear useful in defining cases of bronchiolitis…